已发表论文

— 聚乙烯亚胺 (Polyethylenimine) 基础的微/纳米颗粒作为疫苗佐剂

 

Authors Shen C, Li J, Zhang Y, Li Y, Shen G, Zhu J, Tao J

Received 25 March 2017

Accepted for publication 12 June 2017

Published 31 July 2017 Volume 2017:12 Pages 5443—5460

DOI https://doi.org/10.2147/IJN.S137980

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Alexander Kharlamov

Peer reviewer comments 2

Editor who approved publication: Dr Lei Yang

Abstract: Vaccines have shown great success in treating and preventing tumors and infections, while adjuvants are always demanded to ensure potent immune responses. Polyethylenimine (PEI), as one of the well-studied cationic polymers, has been used as a transfection reagent for decades. However, increasing evidence has shown that PEI-based particles are also capable of acting as adjuvants. In this paper, we briefly review the physicochemical properties and the broad applications of PEI in different fields, and elaborate on the intracellular processes of PEI-based vaccines. In addition, we sum up the proof of their in vivo and clinical applications. We also highlight some mechanisms proposed for the intrinsic immunoactivation function of PEI, followed by the challenges and future perspectives of the applications of PEI in the vaccines, as well as some strategies to elicit the desirable immune responses.
Keywords: cationic polymers, APCs, immunoactivation, danger signals, anti-infection, anticancer



*作者的正确隶属单位应该包含邮政编码,如下:

 


Chen Shen1
Jun Li1
Yi Zhang
1
Yuce Li
2
Guanxin Shen3
Jintao Zhu2
Juan Tao1



1Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; 2School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, China; 3Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China 

 


请点击这里查看详细更正启事